Home » About Us » Clinical Trials » Roche GX30191 OMASPECT
Roche GX30191 OMASPECT
This trial has ended
Research Title: A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Lampalizumab in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration Who Have Completed a Roche-Sponsored Study
Sponsor: Hoffman La-Roche
Principal Investigator: Robert Stoltz, M.D., PhD
Description: This multicenter open-label extension study is designed to evaluate the safety and tolerability of lampalizumab intravitreal injections in participants with GA secondary to age-related macular degeneration (AMD) who completed 96 weeks of treatment in Studies GX29176 (NCT02247479) or GX29185 (NCT02247531). The extension will enroll participants from the parent studies who received investigational lampalizumab, as well as lampalizumab-naive participants exposed to sham comparator. All participants will receive open-label lampalizumab in the present study.
Start Date: September 2016
Recruitment: Completed
Project Personnel: Leslie Marcus, CCRC; Halie Sklanka, CRC
Location(s): Marietta; 833 Campbell Hill Street, Suite 300, Marietta, GA 30060
Clinical Trial Team
Active Trials
- Amgen 20170542
- Apellis APL2-303 DERBY
- Gemini GEM-NH-001 Clarity 1
- Genentech GR40349 YOSEMITE
- Genentech GR40548 ARCHWAY
- Genentech GR40973 Gallego
- Gyroscope Therapeutics GTSCOPE
- Iveric Bio ISEE2008 GATHER2
- NGM Biopharmaceuticals NGM621-GA-201 CATALINA
- Novartis CRTH258A2303 TALON
- Novartis CRTH258B2305 Kingfisher
- Novartis CRTH258C2302 Raven
- Novo Nordisk NN9535-4352 FOCUS
- Regeneron VGFTe(HD)-DME-1934 PHOTON
- Roche GR40549 PORTAL
- Roche GR40550 PAGODA
- Roche GR40844 LUCERNE
- Roche GR41675 PAVILION
- Roche GR41987 RHONE-X
- SamChungDang SCD411-CP101
- Xbrane XBR1002 XPLORE
Past Trials
- AART C-02-60
- Acucela 4429-202 SEATTLE
- Aerpio AKB-9778-CI-5001 TIME-2b
- Allergan 150998-005 CEDAR
- Allergan 1771-201-008 MAPLE
- Allergan 190342-038 BEACON
- ALLERGAN 206207-012
- AREDS2
- AREDS2 ForeseeHome
- C-09-067 RACE
- DRCR.net Protocol N
- Gemini GEM-NH-002 Clarity 2
- Genentech GR39821
- Graybug GBV-102-002 Altissimo
- HORIZON FVF3426g
- KalVista KVD011-201
- LFG316A2203
- MARINA FVF2598g
- Novartis CSPP100A2244
- Ocriplasmin Research to Better Inform Treatment (ORBIT)
- OPH1002
- OPH1004
- Ophthotech OPH2003
- PDEX
- Regeneron R2176-3-AMD-1417 CAPELLA
- Regeneron R910-3-AMD-1517 ONYX
- Regeneron R910-3-DME-1518 RUBY
- Regeneron VGFTe-OD-1411 PANORAMA
- RIDE FVF4168g
- RISE FVF4170g
- Roche BP 30099 BOULEVARD
- Roche BP29647 AVENUE
- Roche GX29176 CHROMA
- Roche GX30191 OMASPECT
- SAILOR FVF3689g
- SCORE
- SCORE2
- Suprachoroidal Buckling for Retinal Detachment
- Taiwan Liposome Company (TLC) TLC399A2002
- Xcenda C-01-17 ForeseeHome